E-LIB Suche - Ergebnisse für: Cubillo, A.

1

397MO Tislelizumab (TIS) plus chemotherapy (CT) vs placebo ..:

Moehler, M. ; Oh, D-Y. ; Kato, K....
Annals of Oncology. 35 (2024) - p. S160-S161 , 2024

Link: https://doi.org/10.1016/..

2

157TiP A clinical validation study to predict recurrence in..:

Srinivasan, G. ; Hubert, A. ; Purim, O....
Annals of Oncology. 35 (2024) - p. S69-S70 , 2024

Link: https://doi.org/10.1016/..

3

Durvalumab plus tremelimumab for the treatment of advanced ..:

Capdevila, J. ; Hernando, J. ; Teule, A....
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

4

Trifluridine/tipiracil in combination with oxaliplatin and ..:

Bordonaro, R. ; Calvo, A. ; Auriemma, A....
ESMO Open. 6 (2021) 5 - p. 100270 , 2021

Link: https://doi.org/10.1016/..

5

OC-0414 Stereotactic body radiotherapy: neoadjuvant strateg..:

Rubio Rodríguez, M.C. ; Chen-Zhao, X. ; López, M....
Radiotherapy and Oncology. 161 (2021) - p. S309-S310 , 2021

Link: https://doi.org/10.1016/..

6

A prospective observational study of the clinical and patho..:

Chen-Zhao, X. ; Hernando, O. ; López, M....
Clinical and Translational Oncology. 22 (2020) 9 - p. 1499-1505 , 2020

Link: https://doi.org/10.1007/..

7

PCN150 Watch and WAIT Policy Versus Robotic Surgery for Rec..:

Nuñez Alfonsel, J. ; Rodriguez-Pascual, J. ; Ielpo, B....
Value in Health. 23 (2020) - p. S449 , 2020

Link: https://doi.org/10.1016/..

8

Multidisciplinary consensus on cancer management during pre..:

Cubillo, A. ; Morales, S. ; Goñi, E....
Clinical and Translational Oncology. 23 (2020) 6 - p. 1054-1066 , 2020

Link: https://doi.org/10.1007/..

9

A Prospective Observational Study of the Impact of Stereota..:

Rubio, C. ; Chen, X. ; Lopez, M....
International Journal of Radiation Oncology*Biology*Physics. 105 (2019) 1 - p. E243-E244 , 2019

Link: https://doi.org/10.1016/..

10

3:36 PM Abstract No. 375 Early safety from a phase 1, multi..:

Raman, S. ; Pless, M. ; Cubillo, A....
Journal of Vascular and Interventional Radiology. 29 (2018) 4 - p. S161 , 2018

Link: https://doi.org/10.1016/..

11

Population Pharmacokinetics of Liposomal Irinotecan in Pati..:

Adiwijaya, BS ; Kim, J ; Lang, I...
Clinical Pharmacology & Therapeutics. 102 (2017) 6 - p. 997-1005 , 2017

Link: https://doi.org/10.1002/..

12

Clinical Experience and Long Follow-Up of Patients With Liv..:

Rubio, C. ; Hernando, O. ; Sanchez, E....
International Journal of Radiation Oncology*Biology*Physics. 99 (2017) 2 - p. E183-E184 , 2017

Link: https://doi.org/10.1016/..

13

2365 Nanoliposomal irinotecan (MM-398, nal-IRI) population ..:

Ma, W.W. ; Chung, I. ; Lang, I....
European Journal of Cancer. 51 (2015) - p. S458 , 2015

Link: https://doi.org/10.1016/..

14

361 Phase I, open-label, dose-escalating clinical and pharm..:

Hidalgo, M. ; Boni, V. ; Tolcher, A....
European Journal of Cancer. 51 (2015) - p. S74 , 2015

Link: https://doi.org/10.1016/..

15

EP-1243: Neoadjuvant treatment of Klatskin Tumours (KT) wit..:

Hernando Requejo, O. ; López, M. ; Ciervide, R....
Radiotherapy and Oncology. 111 (2014) - p. S69-S70 , 2014

Link: https://doi.org/10.1016/..